Health CanadaGeneral Alert
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in R...
Published: July 30, 2021Recall ID: 62725Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
Additional Source Details
| Field | Value |
|---|---|
| N I D | 62725 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/authorization-casirivimab-and-imdevimab-english-only-labels-use-relation-covid-19 |
| Issue | Product safety |
| Title | Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic |
| Archived | 0 |
| Category | Drugs - Biologic or vaccine |
| Last updated | 2021-07-30 |
| Organization | Marketed health products |